Comparative genomic hybridization reveals novel chromosome deletions in 90 primary soft tissue tumors

Cancer Genetics and Cytogenetics

Volumn 115, Issue 2, 1999, Pages 89-95

  Parente, Fabienne ^a   Grosgeorge, Josiane ^a   Coindre, Jean Michel ^b   Terrier, Philippe ^c   Vilain, Odile ^d   Turc Carel, Claude ^d  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSTITUT BERGONIÉ   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SOFT TISSUE TUMOR;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 2; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IN SITU HYBRIDIZATION; LIPOSARCOMA; NEURILEMMOMA; SOFT TISSUE NEOPLASMS;

EID: 0032714182     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00082-5     Document Type: Article

References (35)

1. Sandberg A.A., Turc-Carel C. The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology. Cancer. 59:1987;387-395.
2. Molenaar W.M., De Jong B., Buist J., Idenburg V.J., Seruca R., Vos A.M., Hoekstra H.J. Chromosomal analysis and classification of soft tissue sarcomas. Lab Invest. 60:1989;266-274.
3. Turc-Carel C., Pedeutour F., Durieux E. Characteristic chromosome abnormalities and karyotype profiles in soft tissue tumors. Curr Top Pathol. 89:1995;73-94.
4. Pedeutour F., Suijkerbuijk R.F., Forus A., Van Gaal J., Van de Klundert W., Coindre J.M., Nicolo G., Collin F., Van Haelst U., Huffermann K., Turc-Carel C. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosom Cancer. 10:1994;85-94.
5. Dati C., Muraca R., Tazartes O., Antoniotti S., Perroteau I., Giai M., Cortese P., Sismondi P., Saglio G., De Bortoli M. c-erB-2 and ras expression levels in breast cancer are correlated and show co-operative association with unfavorable clinical outcome. Int J Cancer. 47:1991;833-838.
6. Wolf M., Aaltonen L.A., Szymanska J., Tarkkanen M., Blomqvist C., Berner J.M., Myklebost O., Knuutila S. Complexity of 12q13-22 amplicon in liposarcoma. microsatellite repeat analysis Genes Chromosom Cancer. 18:1997;66-70.
7. Forus A., Florenes V.A., Maelandsmo G.M., Meltzer P.S., Fodstad O., Myklebost O. Mapping of amplification units in the q13-q14 region of chromosome 12 in human sarcomas. some amplica do not include MDM2 Cell Growth Differ. 4:1993;1065-1070.
8. Forus A., Florenes V.A., Maelandsmo G.M., Fodstad O., Myklebost O. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Genet Cytogenet. 78:1994;165-171.
9. Khatib Z.A., Matsushime H., Valentine M., Shapiro D.N., Sherr C.J., Look A.T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53:1993;5535-5541.
10. Smith S.H., Weiss S.W., Jankowski S.A., Coccia M.A., Meltzer P.S. SAS amplification in soft tissue sarcomas. Cancer Res. 52:1992;3746-3749.
11. Levine A.J., Momand J. Tumor suppressor genes. the p53 and retinoblastoma sensitivity genes and gene products Biochim Biophys Acta. 1032:1990;119-136.
12. Scrable H., Witte D., Shimada H., Seemayer T., Sheng W.W., Soukup S., Koufos A., Houghton P., Lampkin B., Cavenee W. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosom Cancer. 1:1989;23-35.
13. Sreekantaiah C. The cytogenetic and molecular characterization of benign and malignant soft tissue tumors. Cytogenet Cell Genet. 82:1998;13-29.
14. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
15. Kallioniemi A., Kallioniemi O.P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., Waldman F.M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA. 91:1994;2156-2160.
16. Forus A., Weghuis D.O., Smeets D., Fodstad O., Myklebost O., van Kessel A.G. Comparative genomic hybridization analysis of human sarcomas. I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas Genes Chromosom Cancer. 14:1995;8-14.
17. Lafage M., Pedeutour F., Marchetto S., Simonetti J., Prosperi M.T., Gaudray P., Birnbaum D. Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line. Genes Chromosom Cancer. 5:1992;40-49.
18. Marmur J. A procedure for isolation of deoxyribonucleic acid from microorganisms. J Mol Biol. 3:1961;208-218.
19. du Manoir S., Speicher M.R., Joos S., Schröck E., Popp S., Döhner H., Kovacs G., Robert-Nicoud M., Lichter P., Cremer T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet. 90:1993;590-610.
20. Pinkel D., Straume T., Gray J.W. Cytogenetic analysis using quantitative, high sensitivity fluorescence in situ hybridization. Proc Natl Acad Sci USA. 83:1986;2934-2938.
21. Larramendy M.L., Tarkkanen M., Blomqvist C., Virolainen M., Wiklund T., Asko-Seljavaara S., Elomaa I., Knuutila S. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol. 151:1997;1153-1161.
22. Stratton M.R., Moss S., Warren W., Patterson H., Clark J., Fisher C., Fletcher C.D., Ball A., Thomas M., Gusterson B.A. Mutation of the p53 gene in human soft tissue sarcomas. association with abnormalities of the RB1 gene Oncogene. 5:1990;1297-1301.
23. Suijkerbuijk R.F., Olde Weghuis D., Van Den Berg M., Pedeutour F., Forus A., Myklebost O., Glier C., Turc-Carel C., van Kessel A.G. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas. Genes Chromosom Cancer. 9:1994;292-295.
24. Packenham J.P., du Manoir S., Schrock E., Risinger J.I., Dixon D., Denz D.N., Evans J.A., Berchuck A., Barret J.C., Devereux T.R., Ried T. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog. 19:1997;273-279.
25. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet. 6:1997;1177-1183.
26. Karnik P., Chen P., Paris M., Yeger H., Williams B.R. Loss of heterozygosity at chromosome 11p15 in Wilms tumors. identification of two independent regions Oncogene. 17:1998;237-240.
27. McCormick C., Leduc Y., Martindale D., Mattison K., Esford L.E., Dyer A.P., Tufaro F. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nature Genet. 19:1998;158-161.
28. Yeung R.S., Bell D.W., Testa J.R., Mayol X., Baldi A., Grana X., Klinga-Levan K., Knudson A.G., Giordano A. The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene. 8:1993;3465-3468.
29. Biggs P.J., Chapman P., Lakhani S.R., Burn J., Stratton M.R. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene. 12:1996;1375-1377.
30. Edelhoff S., Ayer D.E., Zervos A.S., Steingrimsson E., Jenkins N.A., Copeland N.G., Eisenman R.N., Brent R., Disteche C.M. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins. MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19 Oncogene. 9:1994;665-668.
31. Wuyts W., Van Hul W., Hendrickx J., Speleman F., Wauters J., De Boulle K., Van Roy N., Van Agtmael T., Bossuyt P., Willems P.J. Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet. 5:1997;382-389.
32. Parente F., Gaudray P., Carle G.F., Turc-Carel C. Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridization. Cytogenet Cell Genet. 78:1997;65-68.
33. Herbers J., Schullerus D., Muller H., Kenck C., Chudek J., Weimer J., Bugert P., Kovacs G. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosom Cancer. 19:1997;29-35.
34. Schwerdtle R.F., Winterpacht A., Storkel S., Brenner W., Hohenfellner R., Zabel B., Huber C., Decker H.J. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. Cancer Res. 57:1997;5009-5012.
35. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer. 10:1994;231-243.